A new study found that more than half of the experts who helped write the latest DSM revision had financial ties to the pharmaceutical industry, totaling over 14 million dollars. That is not a conspiracy theory. That is a peer reviewed finding published in the BMJ in 2024.
If you have ever sat across from a clinician while they flipped through a manual deciding what to call your brain, you already know this book carries weight. Real weight. The kind that shapes insurance coverage, prescriptions, and how people see themselves.
I want to talk about what the DSM 5 actually is, what it has genuinely done well, and why so many people, including plenty of mental health professionals, think parts of it are broken.
What Is the DSM 5 and What Is It Used For
The Diagnostic and Statistical Manual of Mental Disorders, currently in its DSM-5-TR edition, is the handbook the American Psychiatric Association publishes to define and classify mental health conditions. According to the APA’s own description, the manual exists to provide a common language for clinicians, so that an ADHD diagnosis in Philadelphia means the same thing as an ADHD diagnosis in Seattle.
That sounds simple. It is not.
Before the first DSM was published in 1952, the United States was running at least five separate, incompatible diagnostic systems across asylums, the military, the VA, and prisons. Comparing data across institutions was nearly impossible. The DSM was built to fix that.
So credit where it is due. What is the DSM 5 used for, practically speaking? Insurance reimbursement. Research consistency. A shared vocabulary between your therapist, your psychiatrist, and your primary care doctor. Without it, the entire system of diagnosis and treatment in this country would be even messier than it already feels.
I did not see any of that common language in action until I was sitting in a clinician’s office getting formally diagnosed myself. At no point before that did anyone walk me through the actual DSM criteria. When they finally did, it felt validating. It was like putting on glasses for the first time.
That is the side of the DSM most people experience, the moment it gives you language for something you have been living with for years. But that same manual has a much messier side once you look at how it was built.
Why So Many People Question DSM 5 Reliability
Here is where it gets complicated.
When the DSM-5 field trials were run before publication, they found lower diagnostic reliability than previous editions and the general body of psychiatric research, which is a fancy way of saying two different clinicians, looking at the same patient, were less likely to land on the same diagnosis than expected. That finding generated real criticism inside the field itself, not just from outside skeptics.
One explanation researchers offer is that this might reflect a more honest measurement method rather than DSM-5 specifically being worse. Earlier editions may have looked more reliable simply because the way reliability was tested was less rigorous.
Either way, it raises a fair question. If two trained professionals can review the same symptoms and reach different conclusions, how much weight should any single label carry?
I am not a licensed mental health professional, and nothing in this post is a substitute for working with one. But I do think it is worth knowing that even psychiatry’s own researchers have flagged this issue.
The Categorical Problem
Most DSM diagnoses work like a checklist. You either meet enough criteria for a label, or you do not. There is no in between box.
The problem is that most psychiatric patients do not present cleanly. Research on comorbidity shows that people are diagnosed with multiple conditions at a rate higher than the overall rate for any single diagnosis, something researchers call the force of comorbidity. ADHD, anxiety, and depression showing up together is not the exception. It is closer to the norm.
This is part of why the National Institute of Mental Health, under then director Thomas Insel, redirected its own research funding away from strict DSM categories toward a more biology first framework. Insel stated plainly that DSM diagnoses are based on a consensus about symptom clusters, not an objective lab measure, the way a blood test confirms diabetes.
The DSM and Money: A Real Conflict of Interest Problem
This is the part that tends to surprise people.
A 2024 cross sectional analysis published in the BMJ found that 65 of 116 DSM-5-TR panel and task force members, just over 56 percent, received a combined 14.6 million dollars in industry payments between 2016 and 2019. Much of it was not properly disclosed under the APA’s own policy.
The study’s authors were careful to note this does not prove the payments changed anyone’s decisions. But they argued the financial ties “can lead to implicit bias, compromise the research process, and erode public trust,” regardless of intent.
Current APA policy allows panel members up to 10,000 dollars per year from industry sources and up to 50,000 dollars in pharmaceutical stock holdings, without requiring disclosure of the exact dollar amount received. Critics argue that threshold is simply too permissive for a manual with this much influence over who gets medicated and for what.
This is exactly the kind of thing I pay attention to as a content creator and mental health advocate. I am not anti DSM. The diagnosis it gave me genuinely helped me get support. But I follow the studies closely enough to know the manual has real, documented blind spots, and the money is only part of it. Some of the most well established blind spots show up in who gets accurately diagnosed in the first place, particularly women, people of color, and the LGBTQIA+ community.
DSM 5 Stigmas vs Reality
Myth: The DSM is based on lab tests, like a blood test for diabetes. Reality: DSM diagnoses come entirely from clusters of reported and observed symptoms, agreed on by committee, not from any blood test or brain scan. There is no biological marker behind your chart.
Myth: A psychiatric diagnosis is purely objective and free of clinician bias. Reality: It is not. One peer reviewed study found Black patients were nearly twice as likely as white patients to receive a schizophrenia diagnosis with similar presenting symptoms, a gap researchers attribute largely to clinician bias rather than any actual difference in prevalence.
Myth: Most people with a diagnosis have one clean, isolated condition. Reality: Comorbidity is the norm. Most psychiatric patients carry multiple overlapping diagnoses, which challenges the idea that these categories represent truly separate conditions in the first place.
Different Ways to Think About This: Multiple Perspectives
There is more than one valid lens here, and you get to decide which resonates with your own life.
Perspective one: the DSM is flawed but necessary. Without a shared diagnostic language, insurance, research, and treatment coordination collapse into chaos. The APA frames the manual’s core value as consistency, not perfection.
Perspective two: the categorical model is the wrong tool entirely. Mental health does not have a confirmed biological test the way heart disease does. Forcing fluid human experience into fixed yes or no boxes produces exactly the reliability and comorbidity problems researchers keep documenting. This is the position that led NIMH to fund its own alternative research framework.
Perspective three: the process itself needs structural reform. Even people who believe in the DSM’s basic premise argue the financial conflict of interest policies have not gone far enough to protect the integrity of what gets added, removed, or redefined.
That comorbidity research from perspective two is something I think about with my own diagnoses. I carry ADHD, depression, anxiety, and existential OCD, and at no point have I ever questioned whether those are really four separate things or one thing wearing different masks. To me they are separate, even though I know one can easily set off another. I just try to manage that overlap in the safest, healthiest way I can, which usually means paying attention to which one is driving a hard day before I try to fix it.
What You Can Actually Do With This Information
Knowing the DSM has real, documented limitations does not mean throwing the whole system out. It means using it as an informed patient instead of a passive one.
Ask your clinician if they use a structured diagnostic interview. Research shows structured tools reduce reliance on subjective judgment alone, which can improve diagnostic accuracy.
Stop treating overlapping diagnoses as a personal failure. If you carry ADHD plus anxiety plus depression, that pattern has a name in the research, the force of comorbidity, and it is well documented, not a sign you are uniquely broken.
Separate DSM criteria from social media checklists. Actual DSM criteria require clinically significant impairment across multiple settings, not just relatable symptoms in a video.
If you are part of a racial or ethnic minority and have concerns about a psychotic spectrum diagnosis, consider asking for a second opinion or a structured clinical interview. Research suggests this can reduce, though not eliminate, documented racial disparities in schizophrenia diagnosis.
If you were diagnosed as an adult, know you are statistically normal, not late. More than half of adults with a current ADHD diagnosis were first diagnosed in adulthood, not childhood, according to CDC data.
Read the APA’s own stated purpose for the manual before forming an opinion on it. Understanding what the DSM is actually designed to do, create a shared clinical language, versus what it is not designed to do, provide a lab confirmed biological test, changes how you read your own chart.
Frequently Asked Questions About the DSM 5
What is the DSM 5 used for?
It is the handbook clinicians use to diagnose mental health conditions consistently, support insurance billing, and standardize research across institutions. It gives every provider a shared reference point so a diagnosis means the same thing no matter who delivers it.
Is the DSM 5 reliable?
It depends on the diagnosis and the clinician. Field trials before publication showed lower reliability for several categories than expected, though some researchers argue this reflects more honest measurement rather than a uniquely flawed manual.
Why do people criticize the DSM?
The most common criticisms involve documented pharmaceutical industry financial ties among contributors, the categorical checklist model not matching how overlapping symptoms actually present, and clinician bias affecting diagnosis rates across racial groups.
Does the pharmaceutical industry influence the DSM?
A 2024 BMJ study found over half of DSM-5-TR panel members had financial relationships with pharmaceutical companies totaling 14.6 million dollars, much of it undisclosed. The study could not prove this changed outcomes, but flagged it as a transparency concern.
Is ADHD overdiagnosed in adults?
It is genuinely debated. Diagnosis rates roughly doubled between 2007 and 2016, and the U.S. now diagnoses adult ADHD at a higher rate than the estimated global prevalence, which some researchers see as overdiagnosis and others see as catching up on decades of underdiagnosis, especially in adults who were missed as children.
Holding Two Things at Once
You can believe a diagnosis genuinely changed your life and still believe the system that produced it has real, fixable problems. Those two things are not in conflict. They are just both true, the same way most of us walking around with two or three labels stapled together are both true. Messy and real at the same time.
Before I had a diagnosis, I did not have any of this research. I just had a story I had written about myself, and it was not a kind one. I assumed everything was my fault. I needed to work harder. I needed to study harder. I needed to be better. I thought I just was not trying hard enough, that I was lazy and unmotivated, and I would beat myself up over it constantly.
Getting an actual diagnosis did not erase every flaw in the system that produced it. But it did finally give that internal narrative somewhere to go. I had never talked about my own brain publicly before, not in this context. Once I had language for what was actually happening in it, the brain became one of the most fascinating things I have ever studied, and that fascination is honestly a big part of why this platform exists.
A flawed manual still handed me something true about myself. Both of those things get to be real at the same time.
If you want more breakdowns like this on what the research actually says about your brain, not just what social media says, I cover a lot of this on the blog. You might also like The Biology of the ADHD Guilt Cycle and How to Find Grace or the full Mental Health Resources Hub if you want to go research clinicians or structured interview tools for yourself.
Sources
- Cosgrove L, et al. “Undisclosed financial conflicts of interest in DSM-5-TR: cross sectional analysis.” BMJ, 2024. https://www.medscape.com/viewarticle/dsm-5-panel-members-received-14-2m-undisclosed-industry-2024a10000pa
- American Psychiatric Association. “What is the DSM?” Psychiatry.org, accessed 2026. https://www.psychiatry.org/patients-families/what-is-the-dsm
- “Method Matters: Understanding Diagnostic Reliability in DSM-IV and DSM-5.” PMC, National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC4573819/
- Bruno A, Iannuzzo F, Muscatello MRA. “Comorbidity from a Categorical to a Transdiagnostic-Dimensional Approach.” Clinical Neuropsychiatry, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10016098/
- Insel T. “Transforming Diagnosis.” NIMH Director’s Blog, April 29, 2013, archived mirror via PsychRights. https://psychrights.org/2013/130429NIMHTransformingDiagnosis.htm
- “Racial and Ethnic Disparities in the Diagnosis and Early Treatment of First-Episode Psychosis.” Schizophrenia Bulletin Open, Oxford Academic, 2024. https://academic.oup.com/schizbullopen/article/5/1/sgae019/7734867
- Cosgrove L, Krimsky S. “A Comparison of DSM-IV and DSM-5 Panel Members’ Financial Associations with Industry.” PLOS Medicine, 2012. https://journals.plos.org/plosmedicine/article?id=10.1371%2Fjournal.pmed.1001190
- Staley BS, et al. “Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults.” MMWR, CDC, 2024. https://www.cdc.gov/mmwr/volumes/73/wr/mm7340a1.htm
Much love. Good vibes. – Ky
